Increased interleukin-10 serum levels in patients with solid tumours

Claudio Fortis, Marco Foppoli(Vita-Salute San Raffaele University), Luca Gianotti(Vita-Salute San Raffaele University), Laura Galli(Vita-Salute San Raffaele University), Giovanni Citterio(Istituti di Ricovero e Cura a Carattere Scientifico), Giuseppe Consogno(Istituti di Ricovero e Cura a Carattere Scientifico), Oreste Gentilini(Vita-Salute San Raffaele University), Marco Braga(Vita-Salute San Raffaele University)

Cancer Letters

June 1, 1996

10.1016/0304-3835(96)04213-9

Cited by 155

Abstract

Related Papers

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

René de Waal Malefyt, John B.A.G. Haanen, Hergen Spits et al.|The Journal of Experimental Medicine|1991|1.9k

Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production

Gianfranco Del Prete, Marco Carli, Fabio Almerigogna et al.|The Journal of Immunology|1993|929

Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation

René de Waal Malefyt, Hans Yssel, J E de Vries|The Journal of Immunology|1993|612

IL-10 inhibits human T cell proliferation and IL-2 production

K Taga, Giovanna Tosato|The Journal of Immunology|1992|486

Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes

Fabienne Willems, Arnaud Marchant, Jean‐Pierre Delville et al.|European Journal of Immunology|1994|386